logo
[breadcrumb_custom]

Tag: OMCL

Stock

Omnicell, Inc. (OMCL) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Omnicell, Inc.’s current trading price is -64.05% away from its 52-week high, while its distance from the 52-week low is 4.01%. The stock’s price range for this period has been between $26.66 and $77.14 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.07 million for the day, a number notably higher than the average daily volume of 0.62 million over the last three months. Omnicell, Inc.’s market performance has been unstable in

THMO
Stock

Omnicell, Inc. (OMCL) Stock: Uncovering 52-Week Market Trends

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Omnicell, Inc.’s current trading price is -62.27% away from its 52-week high, while its distance from the 52-week low is 1.32%. The stock’s price range for this period has been between $28.72 and $77.14 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.06 million for the day, a number notably higher than the average daily volume of 0.58 million over the last three months. Omnicell, Inc. experienced a rather shaky stock market

DOYU
Industry

Omnicell, Inc. (OMCL) Stock: A Year of Declines and Increases

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Omnicell, Inc.’s current trading price is -57.93% away from its 52-week high, while its distance from the 52-week low is 12.99%. The stock’s price range for this time frame has been between $28.72 and $77.14. The trading volume of the company’s shares in the Healthcare reached around 0.78 million for the day, which was evidently higher than the average daily volume of 0.63 million over the last three months. The stock market performance of Omnicell, Inc. has been fairly